Showing results (5821-5830 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|July 13, 2017
Recent Advances in the Function of the 67 kDa Laminin Receptor and its Targeting for Personalized Therapy in CancerAda Pesapane, Pia Ragno, Carmine Selleri, et al.Current Pharmaceutical Design|April 7, 2018
The Effects of Coenzyme Q10 Supplementation on Lipid Profiles Among Patients with Metabolic Diseases: A Systematic Review and Meta-analysis of Randomized Controlled TrialsNasrin Sharifi, Reza Tabrizi, Mahmood Moosazadeh, et al.Current Pharmaceutical Design|September 3, 2016
Methods for Elucidation of DNA-Anticancer Drug Interactions and their Applications in the Development of New DrugsMajus Misiak, Francesco Mantegazza, Giovanni L BerettaCurrent Pharmaceutical Design|September 3, 2016
Emerging Role of G-quadruplex DNA as Target in Anticancer TherapyGraziella Cimino-Reale, Nadia Zaffaroni, Marco FoliniCurrent Pharmaceutical Design|August 30, 2016
Therapeutic Potential of Targeting TREM-1 in Inflammatory Diseases and CancerMaria Carla Bosco, Federica Raggi, Luigi VaresioCurrent Pharmaceutical Design|August 30, 2016
Understanding Tumor-Antigen Presentation in the New Era of Cancer ImmunotherapyDaniela Cerezo-Wallis, Maria S SoengasCurrent Pharmaceutical Design|August 31, 2016
New Biological Insights in the Immunomodulatory Effects of Mucosal Polybacterial Vaccines in Clinical PracticeMarta Tejera-Alhambra, Oscar Palomares, Rebeca Perez de Diego, et al.Current Pharmaceutical Design|August 31, 2016
Allergic Asthma: A Summary from Genetic Basis, Mouse Studies, to Diagnosis and TreatmentCynthia Kanagaratham, Danuta RadziochCurrent Pharmaceutical Design|March 19, 2010
Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapyDavid Hirst, Tracy RobsonCurrent Pharmaceutical Design|March 19, 2010
Nitric oxide control of MYCN expression and multi drug resistance genes in tumours of neural originAntonio Porro, Christophe Chrochemore, Francesco Cambuli, et al.Pageof 1,008